Humana Dirección

Dirección controles de criterios 2/4

El CEO de Humana's es Jim Rechtin, nombrado en Jan 2024, tiene una permanencia de menos de un año. posee directamente un 0% de las acciones de la empresa, con un valor de €4.12K. La antigüedad media del equipo directivo y de la junta directiva es de 1.9 años y 3.8 años, respectivamente.

Información clave

Jim Rechtin

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	0.00001%
Permanencia media de la dirección	2.1yrs
Promedio de permanencia en la Junta Directiva	4yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Jim Rechtin (53 yo)

less than a year

Permanencia

Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Susan Diamond	Chief Financial Officer	3.3yrs	US$4.73m	0.0072% $ 2.4m
Joseph Ventura	Chief Legal Officer	5.6yrs	US$3.10m	0.0060% $ 2.0m
Bruce Broussard	Strategic Advisor	less than a year	US$16.33m	0.073% $ 24.8m
George Renaudin	President of Medicare & Medicaid	1.6yrs	US$3.11m	0.0032% $ 1.1m
Sanjay Shetty	President of CenterWell	1.5yrs	US$4.58m	0.00014% $ 47.4k
James Rechtin	President	less than a year	sin datos	0.000010% $ 3.4k
John-Paul Felter	Senior VP	2.1yrs	sin datos	0.00031% $ 104.9k
Eric Tagliere	Senior VP & CTO	less than a year	sin datos	sin datos
Samir Deshpande	Chief Information Officer	3.7yrs	sin datos	0.010% $ 3.5m
Timothy Huval	Chief Administrative Officer	5.2yrs	US$3.73m	0.0061% $ 2.1m
Lisa Stoner	Vice President of Investor Relations	no data	sin datos	sin datos
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.8yrs	sin datos	0.0090% $ 3.1m

2.1yrs

Permanencia media

51.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de HUM se considera experimentado (2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
James Rechtin	President	less than a year	sin datos	0.000010% $ 3.4k
Kurt Hilzinger	Independent Chairman of the Board	21.2yrs	US$601.30k	0.016% $ 5.5m
Karen Katz	Independent Director	5yrs	US$346.55k	0.00049% $ 165.8k
Frank D'Amelio	Independent Director	21yrs	US$363.55k	0.017% $ 5.8m
Jorge Mesquita	Independent Director	3.6yrs	US$351.59k	0.0018% $ 602.3k
Brad Smith	Independent Director	2yrs	US$311.07k	0.00032% $ 108.3k
Wayne Frederick	Independent Director	4.6yrs	US$364.87k	0.00037% $ 125.2k
David Feinberg	Independent Director	2.5yrs	US$321.52k	0.00037% $ 125.2k
Marcy Klevorn	Independent Director	3.6yrs	US$351.94k	0.00036% $ 121.8k
John Garratt	Independent Director	4.6yrs	US$326.03k	0.0010% $ 351.9k
RaQuel Bono	Independent Director	4yrs	US$345.03k	0.00033% $ 111.7k

4.0yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de HUM se considera experimentada (4.3 años de antigüedad promedio).

Humana Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Announces Management Changes

Chief Financial Officer recently sold €377k worth of stock

High number of new directors

Independent Director recently sold €7.1m worth of stock

Recent updates

Upcoming dividend of US$0.89 per share

Second quarter dividend of US$0.89 announced

Humana Settles for $90 Million Groundbreaking False Claims Act Case Alleging Medicare Part D Prescription Drug Program Fraud

Humana Inc. Declares Cash Dividend, Payable on October 25, 2024

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: US$6.13 (vs US$9.91 in 1Q 2023)

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Dividend of US$0.89 announced

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana Inc. Provides Earnings Guidance for 2024

Humana Announces Limited Layoffs

Upcoming dividend of US$0.89 per share at 0.8% yield

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings released: EPS: US$6.74 (vs US$9.44 in 3Q 2022)

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Upcoming dividend of US$0.89 per share at 0.7% yield

Centerwell Senior Primary Care Introduces In-Home Primary Care

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Second quarter 2023 earnings released: EPS: US$7.70 (vs US$5.50 in 2Q 2022)

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Upcoming dividend of US$0.89 per share at 0.8% yield

Investor sentiment deteriorates as stock falls 15%

Chief Financial Officer recently sold €377k worth of stock

First quarter 2023 earnings released: EPS: US$9.91 (vs US$7.33 in 1Q 2022)

Upcoming dividend of US$0.89 per share at 0.7% yield

High number of new directors

Humana Inc. Declares Cash Dividend, Payable on April 28, 2023

Full year 2022 earnings released: EPS: US$22.20 (vs US$22.79 in FY 2021)

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Humana Inc. to Report Q4, 2022 Results on Feb 01, 2023

Independent Director recently sold €7.1m worth of stock

Upcoming dividend of US$0.79 per share

President recently sold €3.5m worth of stock

Segment President of Retail recently sold €4.1m worth of stock

Third quarter 2022 earnings released: EPS: US$9.44 (vs US$11.91 in 3Q 2021)

Humana Inc. Provides Earning Guidance for Fiscal Year 2022

Humana Inc. Declares Cash Dividend to Stockholders, Payable on January 27, 2023

Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs

Humana Inc. to Report Q3, 2022 Results on Nov 02, 2022

Humana Reportedly Among Firms Looking to Buy Cano Health

Chief Legal Officer recently sold €622k worth of stock

Upcoming dividend of US$0.79 per share

Humana Elects Brad D. Smith to Board of Directors

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, October 28, 2022

Humana Inc. (NYSE:HUM) agreed to acquire Substantially All of the Assets of Inclusa, Inc.

Second quarter 2022 earnings released: EPS: US$5.50 (vs US$4.57 in 2Q 2021)

Humana Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Humana Inc. to Report Q2, 2022 Results on Jul 27, 2022

Humana Inc. Announces Management Changes

Upcoming dividend of US$0.79 per share

Chief Administrative Officer recently sold €1.5m worth of stock

First quarter 2022 earnings released: EPS: US$7.33 (vs US$6.42 in 1Q 2021)

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, Payable on July 29, 2022

Humana Inc. to Report Q1, 2022 Results on Apr 27, 2022

Upcoming dividend of US$0.79 per share

Humana Inc. Announces Executive Changes, Effective March 31, 2022

Humana Board Declares Payment of Quarterly Dividend to Stockholders, Payable on April 29, 2022